A major strength of our study is the inclusion of a substantially greater number of trials of GLP-1 RAs than earlier meta-analysis[16, 20, 21], thus it is the largest completed evaluation of GLP-1 RAs’ effect on hypoglycemia, treatment discontinuation and glycemic level to date. Here, GCG is linked to Hypoglycemia.